Ventyx Biosciences, Inc. (VTYX)
$14.00+0.00%Close
BUYBULL · day 36
Key stats
- Market cap
- $1.0B
- Beta
- 1.27
- P/E (TTM)
- -20.00
- 1W
- +0.21%
- 1M
- +0.65%
- vs SPY 1W
- +0.35%
- vs SPY 1M
- -1.86%
Industry peers
FMP comparable companies · ranked by market cap
- ABSIBUYAbsci Corporation$1.5BCRISISQ 2$8.94-5.89%
- KALVKalVista Pharmaceuticals, Inc.$1.4B$27.00
- RIGLBUYRigel Pharmaceuticals, Inc.$901MBULLQ 9$48.72-3.42%
- MLTXSELLMoonLake Immunotherapeutics$890MCRISISQ -1$10.58-2.53%
- CRVSSELLCorvus Pharmaceuticals, Inc.$859MCRISISQ 12$10.21-6.37%
- VSTMBUYVerastem, Inc.$713MRECOVERYQ 4$8.11-9.70%
- OLMASELLOlema Pharmaceuticals, Inc.$683MCRISISQ -1$7.82-4.62%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 12
- VALUE
- 8
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-14.9%
REV YoY-
ROE-24.9%
EPS YoY-
ROA-23.6%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-20.00
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B5.22
P/FCF-
EV/EBITDA-19.98
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.24
ALTMAN Z-
CURR RATIO17.86
ND/EBITDA-
BETA1.27
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on VTYX?
- LOPJLB’s latest quantitative signal on Ventyx Biosciences, Inc. (VTYX) is BUY in a BULL regime. Signals are updated daily.
- What market regime is VTYX in?
- Ventyx Biosciences, Inc. (VTYX) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Ventyx Biosciences, Inc. (VTYX) do?
- Ventyx Biosciences, Inc. is a biopharmaceutical company in the clinical development phase, specializing in the creation of small molecule therapeutics for inflammatory and autoimmune disorders. The company's primary investigational drug, VTX958, a tyrosine kinase type 2 (TYK2) inhibitor, is currently undergoing Phase I clinical trials. This compound aims to address a range of immune-mediated co…